Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets

Additional Information

REPORT SCOPEINTRODUCTION

STUDY GOALS AND OBJECTIVES

This BCC Research report, Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets, provides an overview of the current overall state of the sample preparation industry for life science research focusing on the genomics, epigenomics, and proteomics segments. It describes existing products on the market, and a detailed analysis of the competitive environments, including new potential markets for novel products and assay development. This study includes information about significant players, trends, and obstacles and other information affecting this market and its different segments.

REASONS FOR DOING THIS STUDY

Experimental procedure and technical protocols are the basis for a successful scientific project. Sample preparation steps are often the main “bottleneck” or foundation for further downstream analysis and workflow.

Reagents companies started to recognize commercial potential in providing the required reagents, kits, and assays that help to facilitate scientific work by reducing time, labor, and even costs. Slowly, sample preparation products are evolving into a specific market space with its own trends, influences, and challenges.

Although it is part of the life science reagents and tools industry in general, the sample preparation segment exhibits specific characteristics and differences in its market participants and competitive landscape.

This report highlights the main segments in the sample preparation industry: genomics, proteomics, and epigenomics. It discusses its major players, current and future trends and influences. Drivers and challenges in each segment of this industry are described in detail, including forecasts for the next 5 years.

SCOPE AND FORMAT

This report is essentially a business tool that can help market players evaluate new commercial opportunities in the sample preparation market for genomics, proteomics, and epigenomics research. The geographic scope of this study is global. This market is complex and consists of many different segments, each of which is affected differently by scientific and technological developments. This report identifies the main positive and negative factors affecting each segment, and forecasts market growth, future trends, and product and assay development in every major segment of this market.

METHODOLOGY AND INFORMATION SOURCES

Both primary and secondary research methodologies were used in preparing this study. Initially, a comprehensive and exhaustive search of the literature on drug discovery and already marketed products was conducted. These secondary sources included drug discovery and science-related journals, textbooks, press releases, marketing literature, other product/promotional literature, annual reports, security analyst reports, and other publications. A patent search and analysis were also conducted.

In a second phase, a series of semi-structured interviews was conducted with company representatives, bench scientists, marketing representatives, and other personnel at biotechnology and pharmaceutical companies. Other sources included academics, technology, and consulting companies. Subsequent analysis of the documents and interviews notes was iterative.

INTENDED AUDIENCE

This report is intended for business development professionals, entrepreneurs, and other investors who need to fully understand and properly evaluate each segment of the market for sample preparation in genomics, proteomics, and epigenomics research. It provides insights into the market positions of major companies, and shows new opportunities otherwise overlooked or less known to the business community.

ANALYST CREDENTIALS

Dr. Marianna Tcherpakov has more than 7 years experience as a bench scientist specializing in biochemistry, cell biology, and industrial assay development. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with different research field trends and likely future developments.